Flagship Plans To Distribute New Fund To About Two Dozen Companies

Executive Appointments Amid Biopharma-Ag Cross-Pollination

The venture capital firm announced a $3.6bn raise for Fund VIII and side funds, which it plans to invest across human health, AI and sustainability-focused companies.

• Source: Shutterstock

Flagship Pioneering has more than doubled the funding it has raised since 2021 and will direct it toward building more than a dozen companies across human health, artificial intelligence and sustainability. The plan will underscore the venture capital firm’s therapeutic area-agnostic approach and cross-pollination across the three areas.

The Cambridge, MA-based firm said 10 July that it raised $3.6bn in new funding, including $2.6bn for Fund VIII and side funds worth $1bn that include sector-specific strategic partnerships, with plans to invest that in about 25 companies

Key Takeaways
  • Flagship announced that it raised $3.6bn for Fund VIII and side funds that it plans to invest across about 25 companies.

  • The firm also hired or promoted more than a dozen people to a variety of executive positions

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Financing

More from Business